William Harte

William Harte is a distinguished professional in the fields of pharmaceutical and biomedical research, currently serving as the Chief Translational Officer at Case Western Reserve University since 2011. With extensive experience, William has held various key positions, including Principal at Harte Discovery Services and CEO of Visum Therapeutics Inc. Additionally, William co-founded E3x Bio, focusing on E3 Ubiquitin ligases for drug discovery. Previously, William directed research and development at the Usher Syndrome Initiative and served as Executive Director of Chemistry Research and Discovery at Amgen, leading a large team in small molecule efforts. William's academic credentials include a PhD in Chemistry from Wesleyan University and a BS in Chemistry from Carnegie Mellon University.